moksha8 has established alliances with leading pharmaceutical and biotech companies to provide access to a wide range of high-quality products critical to the care of many patients in central nervous system (CNS), infectious disease and pain/inflammation indications. Our current portfolio is selling approximately $200M USD in annual revenues.

Our key partners today are Pfizer, Roche and BioCryst. moksha8 currently commercializes a portfolio of over 22 products including some of the following brands: